Singapore markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
65.66-0.33 (-0.50%)
As of 10:17AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 215.09B
Enterprise value 239.49B
Trailing P/E 108.05
Forward P/E 18.42
PEG Ratio (5 yr expected) 1.38
Price/sales (ttm)4.78
Price/book (mrq)6.10
Enterprise value/revenue 5.30
Enterprise value/EBITDA 27.92

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 311.28%
S&P500 52-week change 3-8.38%
52-week high 372.12
52-week low 352.65
50-day moving average 368.10
200-day moving average 364.23

Share statistics

Avg vol (3-month) 35.06M
Avg vol (10-day) 36.79M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 83.09B
% held by insiders 10.05%
% held by institutions 118.22%
Shares short (12 Jan 2023) 45.03M
Short ratio (12 Jan 2023) 41.18
Short % of float (12 Jan 2023) 4N/A
Short % of shares outstanding (12 Jan 2023) 40.16%
Shares short (prior month 14 Dec 2022) 44.93M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 42.18%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 34.39%
5-year average dividend yield 42.93
Payout ratio 4226.56%
Dividend date 311 Sept 2022
Ex-dividend date 410 Aug 2022
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 4.52%
Operating margin (ttm)22.55%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)5.45%

Income statement

Revenue (ttm)45.16B
Revenue per share (ttm)14.58
Quarterly revenue growth (yoy)11.30%
Gross profit (ttm)27.61B
EBITDA 13.65B
Net income avi to common (ttm)2.04B
Diluted EPS (ttm)0.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.52B
Total cash per share (mrq)1.46
Total debt (mrq)31.27B
Total debt/equity (mrq)88.97
Current ratio (mrq)0.81
Book value per share (mrq)11.35

Cash flow statement

Operating cash flow (ttm)8.83B
Levered free cash flow (ttm)10.39B